Activest Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.9K Sell
420
-1,176
-74% -$54.2K ﹤0.01% 498
2026
Q2
$76.5K Sell
1,596
-4,716
-75% -$203K 0.01% 215
2026
Q1
$232K Sell
6,312
-2,037
-24% -$96.5K 0.04% 138
2025
Q4
$425K Sell
8,349
-7,346
-47% -$376K 0.08% 99
2025
Q3
$871K Buy
15,695
+911
+6% +$53.3K 0.18% 57
2025
Q2
$1.02M Sell
14,784
-358
-2% -$24.4K 0.25% 43
2025
Q1
$1.05M Buy
15,142
+4,376
+41% +$361K 0.28% 45
2024
Q4
$926K Buy
10,766
+10,224
+1,886% +$1.11M 0.26% 45
2024
Q3
$64.5K Buy
542
+500
+1,190% +$66.7K 0.02% 153
2024
Q2
$6K Hold
42
– – ﹤0.01% 335
2024
Q1
$5.39K Buy
+42
New +$5K ﹤0.01% 252

Other funds holding NVO

Activest Wealth Management's NVO Position: Q3 2026 in Review

Activest Wealth Management reduced its Novo Nordisk (NVO) stake by 74% in Q3 2026, selling an estimated $54.2K and leaving 420 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #498.

Activest Wealth Management first reported a position in NVO in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.05M in Q1 2025. 1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Activest Wealth Management held 420 shares of Novo Nordisk worth $15.9K as of Q3 2026.
  • Activest Wealth Management sold 1,176 Novo Nordisk shares in Q3 2026, an estimated $54.2K.
  • Novo Nordisk made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #498 holding.
  • Activest Wealth Management first reported a position in Novo Nordisk in Q1 2024 and has held it in 11 quarters since.
  • Activest Wealth Management's Novo Nordisk position peaked at $1.05M in Q1 2025.
  • 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.